20th International Symposium on Electro- and Liquid-Phase Separation Techniques (ITP2013)
The 20th International Symposium on Electro- and Liquid-Phase Separation Techniques (ITP2013) will take place at the Hotel Beatriz Atlantis & Spa, Tenerife, Spain from 6?9 October 2013.
The 20th International Symposium on Electro- and Liquid-Phase Separation Techniques (ITP2013) will take place at the Hotel Beatriz Atlantis & Spa, Tenerife, Spain from 6–9 October 2013.
The ITP symposium is the 20th in the series and has been previously held at locations throughout Europe and North America. The co-chairs of ITP2013 are Alejandro Cifuentes from the Spanish National Research Council (CSIC) (Madrid, Spain) and Javier Hernández‑Borges from the University of La Laguna, Tenerife, Spain.
The dynamic programme of ITP2013 will highlight analytical technologies that provide electro- and liquid-phase separations, including capillary electrophoresis CE), microchip CE, high performance liquid chromatography (HPLC), ultrahigh-pressure liquid chromatography (UHPLC), micro- and nano‑scale HPLC, electrokinetic chromatography (EKC), electrochromatography (EC), two-dimensional electrophoresis (2-DE) and hyphenated techniques.
ITP2013 is structured over four days beginning with an initial workshop. This will be followed by plenary lectures and contributed communications, as well as poster sessions, vendor seminars and an exposition. Organized sessions will cover glycomics, proteomics foodomics, metabolomics, genetic analysis, DNA sequencing and separation, miniaturization and microfluidics, bioanalysis, biotechnology, (bio)pharmaceutical analysis, environmental analysis, food analysis, multidimensional separations, hyphenated techniques, novel instrumentation,and sample preparation.
To promote young researchers within the field, a Young Scientist Session will be held, as well as a poster award competition. The top presentations in both will receive awards.
The Scientific Committee of the symposium is permanently formed by a group of renowned scientists from within the field including: Alejandro Cifuentes (Madrid, Spain); Ziad El Rassi (Stillwater, USA); Salvatore Fanali (Rome, Italy); Frantisek Foret (Brno, Czech Republic); Bohuslav Gas (Prague, Czech Republic); Takeshi Hirokawa (Hiroshima, Japan); Stellan Hjerten (Uppsala, Sweden); Vaclav Kasicka (Prague, Czech Republic); Ernst Kenndler (Vienna, Austria); Blanca Lapizco-Encinas (Rochester, USA); Marja-Liisa Riekkola (Helsinki, Finland); and Marina Tavares (Sao Paulo, Brazil).
Tenerife is one of the seven Canary Islands that are part of Spanish territory in the Atlantic Ocean, located 100 km off the north-western coast of continental Africa. Together with the islands of Azores, Madeira and Cape Verde, they constitute a group of archipelagos called “Macaronesia”. Tenerife has an optimum climate throughout the year, with unique and beautiful landscapes that are worth seeing. In particular, the volcano and highest mountain of Spain located in the middle of the island, Las Cañadas del Teide National Park, was declared a UNESCO World Heritage natural site in 2007. The ITP2013 venue is located on the north coast of the island at Puerto de la Cruz. It is a lively, cosmopolitan town that has preserved its traditional seaside atmosphere, as well as offering a wide range of leisure activities.
Lunches, dinners, coffee breaks and a full social programme that includes a visit to Las Cañadas del Teide National Park are included in the conference fee.
In addition, this year ITP2013 will connect for the first time with the XIII Meeting of the Spanish Society of Chromatography and Related Techniques (SECyTA2013) which will be held at the same place on 8–11 October 2013.
Important deadlines include: 31 May 2013 for abstract submissions and 30 June 2013 for early registration and special prices at local hotels.
For more detailed information visit: ww.itp2013.ull.es
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
